Bionano Genomics, Inc. - stock earnings

BNGO Quarterly earnings

DateEarningsRevenue
2023Q3 -112.6 million USD 9.3 million USD
2023Q2 -38.9 million USD 8.7 million USD
2023Q1 -37.1 million USD 7.4 million USD
2022Q4 -38.7 million USD 8.2 million USD
2022Q3 -31.8 million USD 7.2 million USD
2022Q2 -32.2 million USD 6.7 million USD
2022Q1 -30.0 million USD 5.7 million USD
2021Q4 -22.9 million USD 6.3 million USD
2021Q3 -20.8 million USD 4.7 million USD
2021Q2 -18.8 million USD 3.9 million USD
2021Q1 -9.9 million USD 3.2 million USD
2020Q4 -11.7 million USD 4.0 million USD
2020Q3 -10.8 million USD 2.2 million USD
2020Q2 -8.1 million USD 1.2 million USD
2020Q1 -10.5 million USD 1.1 million USD
2019Q4 -7.9 million USD 2.8 million USD
2019Q3 -6.4 million USD 3.3 million USD
2019Q2 -7.7 million USD 2.2 million USD
2019Q1 -7.9 million USD 1.9 million USD
2018Q4 -6.4 million USD 4.0 million USD
2018Q3 -4.9 million USD 2.8 million USD
2018Q2 -3.3 million USD 3.4 million USD
2018Q1 -3.8 million USD 1.8 million USD
2017Q4 -5.9 million USD 2.8 million USD
2017Q3 -5.1 million USD 2.7 million USD
2017Q2 -6.7 million USD 2.2 million USD
2017Q1 -5.7 million USD 1.7 million USD
2016Q4 -18.8 million USD 6.8 million USD

BNGO Yearly earnings

DateEarningsRevenue
2023 -227.3 million USD 33.6 million USD
2022 -132.6 million USD 27.8 million USD
2021 -72.4 million USD 18.0 million USD
2020 -41.1 million USD 8.5 million USD
2019 -29.8 million USD 10.1 million USD
2018 -18.5 million USD 12.0 million USD
2017 -23.4 million USD 9.5 million USD
2016 -18.8 million USD 6.8 million USD

BNGO

Price: $0.86

52 week price:
0.75
11.80

Earnings Per Share: -6.81 USD

P/E Ratio: -0.16

Exchange: NCM

Sector: Healthcare

Industry: Medical Instruments & Supplies

Volume: 6.9 million

Market Capitalization: 55.8 million

Links: